Company: ZDAN
Filing Date: 2025-02-18
Form Type: DRS/A
Source: 0001683168-25-001085
Chunk: 127

Company: Zerolimit Technology Holding Co. Ltd.
Filing Date: 2025-02-18
Form: DRS/A
Chunk 127
---
.

| 68 |

<div align='center'>USE OF PROCEEDS</div>

We estimate that we will
receive net proceeds from this offering of approximately US$[*] million, or approximately US$[*] million if the Underwriter exercises
its over-allotment option in full, after deducting underwriting discounts, non-accountable expense allowance and estimated offering expenses
payable by us. These estimates are based upon an assumed initial public offering price of US$[ ] per Ordinary Share.

We plan to use the net proceeds
of this offering (assuming no exercise of the over-allotment option) as follows in the order of priority:

| · | approximately 40%, or US$[*] million for research and development;         |
| · | approximately 25%, or US$[*] million for new product production;           |
| · | approximately 20%, or US$[*] million for marketing and sales activities;   
 and                                                                        |
| · | approximately 15%, or the remaining amount for general corporate purposes, 
 which may include working capital needs and other corporate uses.          |

The amounts and timing of
any expenditures will vary depending on the amount of cash generated by our operations, and the rate of growth, if any, of our business,
and our plans and business conditions. The foregoing represents our intentions as of the date of this prospectus based upon our current
plans and business conditions to use and allocate the net proceeds of this offering. However, our management will have significant flexibility
and discretion in applying the net proceeds of this offering. Unforeseen events or changed business conditions may result in application
of the proceeds of this offering in a manner other than as described in this prospectus.

The foregoing represents
our current intentions based upon our present plans and business conditions to use and allocate the net proceeds of this offering. Our
management, however, will have broad discretion in the application of our net proceeds from this offering, and investors will be relying
on the judgment of our management regarding the application of these proceeds. See “Risk Factors — Risks
Related to this Offering and the Ordinary Shares — You must rely on the judgment of our management as to the use of the
net proceeds from this offering, and such use may not produce income or increase the price of our Ordinary Shares” To the extent
that the net proceeds we receive from this offering are not immediately applied for the above purposes, we plan to invest the net proceeds
in bank deposits and low-risk bank financial products.